Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

Status

Active, not recruiting

NCT ID

NCT05413811

The purpose of this study is to explore whether an anti-cancer medication (5-fluorouracil cream) placed in the vagina after a surgical excision procedure is an acceptable and useful form of treatment for cervical precancer among the woman with HIV infection.

Intervention

5 Fluorouracil (5 FU) Cream, Placebo

Condition

Cervical Cancer, CIN2, CIN3, Human Immunodeficiency Virus, Human Papillomavirus

Investigators

Carla Chibwesha, MD, MSc

See list of participating sites